ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 70 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 380 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 380 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 380 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $1,000 | 0.0% | 380 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,000 | -50.0% | 380 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 380 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | +100.0% | 380 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | -66.7% | 380 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $3,000 | 0.0% | 380 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | -25.0% | 380 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $4,000 | -20.0% | 380 | 0.0% | 0.00% | -25.0% |
| Q2 2016 | $5,000 | +25.0% | 380 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $4,000 | -55.6% | 380 | 0.0% | 0.00% | -57.1% |
| Q4 2015 | $9,000 | +50.0% | 380 | 0.0% | 0.01% | +40.0% |
| Q3 2015 | $6,000 | -33.3% | 380 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $9,000 | – | 380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |